Calendar

Financial releases

Date Title  
Toggle Summary AbbVie Reports First-Quarter 2022 Financial Results
Reports First-Quarter Diluted EPS of $2.51 on a GAAP Basis, an Increase of 26.1 Percent; Adjusted Diluted EPS of $3.16 , an Increase of 9.3 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share related to Acquired IPR&D and Milestones Expense 1 Delivers First-Quarter Net Revenues
Toggle Summary AbbVie to Host First-Quarter 2022 Earnings Conference Call
NORTH CHICAGO, Ill. , April 14, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2022 financial results on Friday, April 29, 2022 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT .
Toggle Summary AbbVie to Present at the Cowen 42nd Annual Health Care Conference
NORTH CHICAGO, Ill. , March 1, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen 42 nd Annual Health Care Conference on Tuesday, March 8, 2021 . Robert A. Michael , vice chairman, finance and commercial operations and chief financial officer, Michael E.
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Feb. 17, 2022 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share.  The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022 .
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
- Reports Full-Year Diluted EPS of $6.45 on a GAAP Basis, an Increase of 137.1 Percent; Adjusted Diluted EPS of $12.70, an Increase of 20.3 Percent - Delivers Full-Year Net Revenues of $56.197 Billion on a GAAP Basis, an Increase of 22.7 Percent; Adjusted Net Revenues Were $56.122 Billion -
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 5, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT .
Toggle Summary AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 . Members of AbbVie's executive leadership team will present virtually at 2:45 p.m. CT , including Robert A.
Toggle Summary AbbVie to Present at the Evercore ISI Conference
NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 4 th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief
Toggle Summary AbbVie to Present at the Piper Sandler Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33 rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief
Toggle Summary AbbVie to Present at the Wolfe Research Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and